Loading…
Clara cell protein in full-term pregnancies: The influence of intrauterine growth restriction
Background Clara cell protein (CC16) is an immunomodulatory/anti‐inflammatory broncho‐alveolar‐derived molecule and a biomarker of pulmonary epithelial cells maturity and alveolo‐capillary membrane injury. Intrauterine growth‐restricted (IUGR) neonates may present with structural lung immaturity, im...
Saved in:
Published in: | Pediatric pulmonology 2010-12, Vol.45 (12), p.1186-1191 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Clara cell protein (CC16) is an immunomodulatory/anti‐inflammatory broncho‐alveolar‐derived molecule and a biomarker of pulmonary epithelial cells maturity and alveolo‐capillary membrane injury. Intrauterine growth‐restricted (IUGR) neonates may present with structural lung immaturity, impaired immunocompetence and increased risk for respiratory infections and chronic obstructive lung disease in later life.
Objectives
To investigate circulating CC16 concentrations in maternal, fetal, and neonatal samples from IUGR and appropriate for gestational age (AGA) pregnancies.
Methods
Serum CC16 concentrations were determined by EIA in 40 mothers and their 20 IUGR and 20 AGA singleton full‐term fetuses–neonates on postnatal days 1 (N1) and 4 (N4).
Results
No significant differences in CC16 concentrations were observed between IUGR and AGA groups. In both groups, maternal CC16 concentrations were lower compared to N1 and N4 ones (P |
---|---|
ISSN: | 8755-6863 1099-0496 |
DOI: | 10.1002/ppul.21305 |